IL33 and Alzheimer disease: LPS- and Aβ42-treated monocytes from MCI patients and controls downregulated IL-1β expression and also increased IL-10 secretion in control monocytes, whereas AD monocyte expression of IL-33 and IL-10 remained unchanged (Saresella et al., 2020).